For advanced lung cancer, immune therapy plus chemo prolongs survival | RSS News Feed

For advanced lung cancer, immune therapy plus chemo prolongs survival - Latest News

RSS Feed for this news: For advanced lung cancer, immune therapy plus chemo prolongs survival

For advanced lung cancer, immune therapy plus chemo prolongs survival

Patients with newly diagnosed advanced lung cancer who received an immunotherapy drug plus standard chemotherapy lived significantly longer than those who got chemo alone, according to a new study that is expected to change the way such patients are treated. read more

New hope for lung cancer patients Study: Immunotherapy plus chemo prolongs survival

Patients with newly diagnosed advanced lung cancer who received an immunotherapy drug plus ... therapy group who were alive and whose disease had not gotten worse at a year was about 34 percent, about double the proportion for the chemo-only group. read more

Pembrolizumab Plus Chemo Improved Survival in Advanced NSCLC

The addition of the immune checkpoint inhibitor pembrolizumab to chemotherapy yielded significantly longer overall survival (OS) than chemotherapy alone in patients with newly diagnosed metastatic nonsquamous non–small-cell lung cancer (NSCLC), according ... read more

Looking for another news?


Immunotherapy Drug Significantly Boosts Odds Of Survival For Lung Cancer Patients

(Loftus and Rockoff, 4/16) The Washington Post: For Advanced Lung Cancer, Immune Therapy Plus Chemo Prolongs Survival Scientists who weren't involved in the study agreed that it was highly significant. H. Jack West, an oncologist at Swedish Medical Center ... read more

Immune therapy scores big win against lung cancer in study

Another study found that an immunotherapy combo — the Bristol-Myers Squibb drugs Opdivo and Yervoy — worked better than chemo for delaying the time until cancer worsened in advanced lung ... survival, as Keytruda did. All of these immune therapy ... read more

For advanced lung cancer, immune therapy plus chemo prolongs survival

Patients with newly diagnosed advanced lung cancer who received an immunotherapy drug plus standard chemotherapy lived significantly longer than those who got chemo alone, according to a new study that is expected to change the way such patients are treated. read more

Immune Therapy Scores Big Win Against Lung Cancer

For the first time, a treatment that boosts the immune system greatly improved survival ... chemo for the most common form of advanced lung cancer, but doctors have been leery to use it because that was based on a small study that did not show whether it ... read more

For advanced lung cancer, immune therapy plus chemo prolongs survival

Patients with newly diagnosed advanced lung cancer who received an immunotherapy drug plus standard chemotherapy lived significantly longer than those who got chemo alone, according to a new study that is expected to change the way such patients are treated. read more

For advanced lung cancer, immune therapy plus chemo prolongs survival

Patients with newly diagnosed advanced lung cancer who received an immunotherapy drug plus standard chemotherapy lived significantly longer than those who got chemo alone, according to a new study that is expected to change the way such patients are treated. read more

For advanced lung cancer, immune therapy plus chemo prolongs survival

Patients with newly diagnosed advanced lung cancer who received an immunotherapy drug plus standard chemotherapy lived significantly longer than those who got chemo alone, according to a new study that is expected to change the way such patients are treated. read more


FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us